PEDERZOLI, FILIPPO
 Distribuzione geografica
Continente #
AS - Asia 1.232
NA - Nord America 1.028
EU - Europa 611
SA - Sud America 357
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 2
Totale 3.264
Nazione #
US - Stati Uniti d'America 975
SG - Singapore 409
HK - Hong Kong 313
CN - Cina 311
BR - Brasile 304
SE - Svezia 178
IT - Italia 126
VN - Vietnam 92
DE - Germania 88
FI - Finlandia 46
RU - Federazione Russa 42
GB - Regno Unito 36
CA - Canada 29
IN - India 24
FR - Francia 21
PL - Polonia 21
MX - Messico 20
AR - Argentina 19
JP - Giappone 15
NL - Olanda 13
ZA - Sudafrica 13
ID - Indonesia 10
ES - Italia 9
IE - Irlanda 9
AT - Austria 8
EC - Ecuador 8
EG - Egitto 8
IR - Iran 8
PY - Paraguay 8
TR - Turchia 8
CO - Colombia 7
IQ - Iraq 7
BD - Bangladesh 6
AE - Emirati Arabi Uniti 5
UZ - Uzbekistan 5
VE - Venezuela 5
PK - Pakistan 4
EU - Europa 3
TW - Taiwan 3
UA - Ucraina 3
XK - ???statistics.table.value.countryCode.XK??? 3
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
KW - Kuwait 2
LT - Lituania 2
MA - Marocco 2
NI - Nicaragua 2
TN - Tunisia 2
UY - Uruguay 2
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
SA - Arabia Saudita 1
SR - Suriname 1
Totale 3.264
Città #
Hong Kong 313
Singapore 204
Dallas 167
Ashburn 127
New York 85
Shanghai 75
Hefei 53
Beijing 48
Los Angeles 48
Lawrence 38
Milan 38
Princeton 38
Ho Chi Minh City 32
Munich 32
Boardman 29
Rome 24
São Paulo 23
Turku 21
Helsinki 18
Moscow 17
Denver 16
Hanoi 16
Montreal 16
Santa Clara 15
Warsaw 15
Tokyo 13
Nuremberg 12
Brooklyn 10
Guangzhou 10
Houston 10
Mumbai 10
Orem 10
Poplar 10
Rio de Janeiro 10
Dublin 9
Johannesburg 9
Atlanta 8
Frankfurt am Main 8
London 8
Stockholm 8
Hanover 7
Phoenix 7
Salvador 7
Boston 6
Brasília 6
Cairo 6
Cesano Boscone 6
Columbus 6
Haiphong 6
Lappeenranta 6
Mexico City 6
Querétaro 6
Seattle 6
Turin 6
Amsterdam 5
Ankara 5
Caxias do Sul 5
Charlotte 5
Chennai 5
Chicago 5
San Francisco 5
The Dalles 5
Toronto 5
Biên Hòa 4
Buffalo 4
Curitiba 4
Da Nang 4
Fortaleza 4
Guayaquil 4
Porto Alegre 4
Pune 4
Quito 4
Segrate 4
São José do Rio Preto 4
Vienna 4
Barueri 3
Belo Horizonte 3
Can Tho 3
City of London 3
Concord 3
Detroit 3
Falkenstein 3
Hangzhou 3
Joinville 3
Mariana 3
Medellín 3
New Delhi 3
Pristina 3
Surakarta 3
Tashkent 3
Thái Bình 3
Verona 3
Woking 3
Abu Dhabi 2
Acaraú 2
Angra dos Reis 2
Aracaju 2
Arvada 2
Asunción 2
Athens 2
Totale 1.901
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 163
Microbiome and bladder cancer 125
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 106
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 104
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 102
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 91
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 90
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 87
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 85
A global approach to improving penile cancer care 84
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 80
Causal contributors to tissue stiffness and clinical relevance in urology 76
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 72
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 72
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 72
A risk calculator predicting recurrence in lymph node metastatic penile cancer 71
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 70
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 69
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 68
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 66
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 65
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 64
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age 63
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 63
Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men 62
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 62
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 61
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 60
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 59
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 58
Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer 55
Risk of health status worsening in primary infertile men: A prospective 10-year follow-up study 54
Topographic modification of the extracellular matrix precedes the onset of bladder cancer 53
Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence 49
Neoadjuvant chemotherapy for lymph node-positive penile cancer: Current evidence and knowledge 49
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 48
Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy 46
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 46
Revolutionizing care for rare genitourinary tumours 46
Re: High blood pressure is a highly prevalent but unrecognised condition in primary infertile men: Results of a cross-sectional study 45
Regenerative and engineered options for urethroplasty 44
Targetable gene fusions and aberrations in genitourinary oncology 44
Re: Undiagnosed Prediabetes is Highly Prevalent in Primary Infertile Men-Results from a Cross-Sectional Study 42
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 41
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 40
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm? 39
Whole exome data prioritization unveils the hidden weight of Mendelian causes of male infertility. A report from the first Italian cohort 36
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 36
Semen infections in men with primary infertility in the real-life setting 35
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 35
The new era of precision urobiome: RE: “Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study” by Chipollini et al 33
The Gut and Urinary Microbiota: A Rising Biomarker in Genitourinary Malignancies 31
Testicular volume in infertile versus fertile white-European men: a case-control investigation in the real-life setting 30
null 1
null 1
null 1
null 1
null 1
null 1
Totale 3.353
Categoria #
all - tutte 20.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 15 5 0 0 0 0 0
2021/2022101 0 10 2 20 3 4 15 9 5 7 3 23
2022/2023319 93 71 26 16 5 36 11 26 15 5 5 10
2023/2024320 11 28 34 31 30 74 10 41 1 4 8 48
2024/20251.146 100 42 16 41 61 78 188 269 123 83 57 88
2025/20261.439 192 239 224 415 288 81 0 0 0 0 0 0
Totale 3.353